0 2

Cited 0 times in

Cited 0 times in

Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC

DC Field Value Language
dc.contributor.authorJames Chih‑Hsin Yang-
dc.contributor.authorSeema Sethi, D.O-
dc.contributor.authorCho, Byoung Chul-
dc.date.accessioned2026-04-03T00:45:55Z-
dc.date.available2026-04-03T00:45:55Z-
dc.date.created2026-04-01-
dc.date.issued2026-02-
dc.identifier.issn0028-4793-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/211753-
dc.languageEnglish-
dc.publisherMassachusetts Medical Society-
dc.relation.isPartOfNEW ENGLAND JOURNAL OF MEDICINE-
dc.relation.isPartOfNEW ENGLAND JOURNAL OF MEDICINE-
dc.titleAmivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC-
dc.typeArticle-
dc.contributor.googleauthorJames Chih‑Hsin Yang-
dc.contributor.googleauthorSeema Sethi, D.O-
dc.contributor.googleauthorCho, Byoung Chul-
dc.identifier.doi10.1056/NEJMc2517120-
dc.relation.journalcodeJ02371-
dc.identifier.eissn1533-4406-
dc.identifier.pmid41740051-
dc.identifier.urlhttps://www.nejm.org/doi/10.1056/NEJMc2517120-
dc.contributor.affiliatedAuthorCho, Byoung Chul-
dc.identifier.scopusid2-s2.0-105031315557-
dc.identifier.wosid001701054700013-
dc.citation.volume394-
dc.citation.number9-
dc.citation.startPage933-
dc.citation.endPage936-
dc.identifier.bibliographicCitationNEW ENGLAND JOURNAL OF MEDICINE, Vol.394(9) : 933-936, 2026-02-
dc.identifier.rimsid92300-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.type.docTypeLetter-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.